🇺🇸 FDA
Patent

US 12128058

Multi-substituent psilocybin derivatives and methods of using

granted A61KA61K31/4045A61K31/675

Quick answer

US patent 12128058 (Multi-substituent psilocybin derivatives and methods of using) held by Enveric Biosciences Canada Inc. expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enveric Biosciences Canada Inc.
Grant date
Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/4045, A61K31/675, A61K31/7028, A61P